Cargando…
Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment
Lung cancer causes more deaths in men and women than any other cancer related disease. Currently, few effective strategies exist to predict how patients will respond to treatment. We evaluated the serum metabolomic profiles of 25 lung cancer patients undergoing chemotherapy ± radiation to evaluate t...
Autores principales: | Hao, Desirée, Sarfaraz, M. Omair, Farshidfar, Farshad, Bebb, D. Gwyn, Lee, Camelia Y., Card, Cynthia M., David, Marilyn, Weljie, Aalim M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819600/ https://www.ncbi.nlm.nih.gov/pubmed/27073350 http://dx.doi.org/10.1007/s11306-016-0961-5 |
Ejemplares similares
-
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
por: Farshidfar, Farshad, et al.
Publicado: (2016) -
Serum metabolomic profile as a means to distinguish stage of colorectal cancer
por: Farshidfar, Farshad, et al.
Publicado: (2012) -
Evaluation of Extraction Protocols for Simultaneous Polar and Non-Polar Yeast Metabolite Analysis Using Multivariate Projection Methods
por: Tambellini, Nicolas P., et al.
Publicado: (2013) -
Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy
por: Hao, Desirée, et al.
Publicado: (2020) -
Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of (1)H-NMR Spectroscopy and Gas Chromatography–Mass Spectrometry
por: McConnell, Yarrow J., et al.
Publicado: (2017)